Themis Medicare Faces Significant Volatility Amid Broader Pharmaceutical Sector Decline

Themis Medicare, a small-cap player in the Pharmaceuticals & Drugs sector, has experienced significant volatility today, hitting a new 52-week low of Rs. 142.3. This decline follows three consecutive days of gains, marking a notable trend reversal. The stock underperformed its sector by 5.74%, reflecting broader market challenges, as the Pharmaceuticals & Drugs industry itself fell by 3.93%.
Today's trading saw Themis Medicare reach an intraday low of Rs. 142.3, representing a drop of 9.65%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish technical trend. Over the past year, Themis Medicare has reported a staggering decline of 37.76%, contrasting sharply with the Sensex's modest gain of 1.75%.

Financial metrics reveal a concerning picture, with a significant drop in net sales and profit after tax in the latest quarter. The company's cash and cash equivalents have also reached a low of Rs. 17.60 crore. Despite a healthy debt servicing capability, indicated by a low Debt to EBITDA ratio of 1.01 times, the stock's valuation appears expensive relative to its peers, with a PEG ratio of 17.1.